基本情報
- 標準SMILES
O=C(O)c1ccccc1-c1ccc(C(F)(F)F)cc1- InChIKey
IQOMYCGTGFGDFN-UHFFFAOYSA-N- 分子式
- C14H9F3O2
- 平均分子量
- 266.21 g/mol
- 単同位体質量
- 266.05546419
概要
Xenalipin is a small molecule drug. Xenalipin has a monoisotopic molecular weight of 266.06 Da.
名称と識別子
- 優先名称
- 4'-(Trifluoromethyl)(1,1'-biphenyl)-2-carboxylic acid
- IUPAC
- 2-[4-(trifluoromethyl)phenyl]benzoic acid
- 現地名
- キセナリピン
- 英語名
- 4-(Trifluoromethyl)-2'-biphenylcarboxylic acid
- 分子式
- C14H9F3O2
- 分子量
- 266.22
名称と別名
名称をさらに表示
データベース識別子
- CAS
84392-17-6- PubChem CID
- 55251
- DTXSID
DTXSID0046565- ChEMBL
CHEMBL2104509- UNII
- 28W00I603X
- EC Number
- 617-563-9
- Nikkaji
- J34.699C
物性
構造計算による物性
- XLogP
- 3.8
- 極性表面積
- 37.3 Ų
- 水素結合供与体数
- 1
- 水素結合受容体数
- 5
- 回転可能結合数
- 2
- 重原子数
- 19
- 形式電荷
- 0
- 複雑度
- 319
物理化学的性質
- 融点
- 169 · 169-171 °C(lit.)
- 沸点
- 335.8 · 335.8±37.0 °C(Predicted)
- 比重(密度)
- 1.326 · 1.326±0.06 g/cm3(Predicted)
- 貯蔵温度
- Sealed in dry,Room Temperature
- 溶解性
- soluble in Methanol
- 外見
- powder to crystal
- 酸解離定数(Pka)
- 3.7 · 3.70±0.36(Predicted)
- 色
- White to Almost white
- BRN
- 7577560 · 7577560
- InChI
- InChI=1S/C14H9F3O2/c15-14(16,17)10-7-5-9(6-8-10)11-3-1-2-4-12(11)13(18)19/h1-8H,(H,18,19)
- InChIKey
- IQOMYCGTGFGDFN-UHFFFAOYSA-N
- SMILES
- C1(C2=CC=C(C(F)(F)F)C=C2)=CC=CC=C1C(O)=O
- CAS データベース
- 84392 · 84392-17-6(CAS DataBase Reference)
化学的性質
化学的特性White solid
安全と法規制
GHS分類
GHS Classification
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 7 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
危険有害性情報
安全データ
- wgk
- 3
- hs_code
- 29162090
- risk_code
- 36/37/38
- hazard_code
- Xi
- safety_code
- 26-36/37/39-36/37
- hazard_class
- IRRITANT
- ストレージクラス
- 11 - Combustible Solids
化学と産業
応用分野
使用Hypolipidemic.
一般的な説明4′-(Trifluoromethyl)-2-biphenylcarboxylic acid (xenalipin) has been tested as an effective hypolipidemic agent in animal species. It has been shown to cause significant reduction in serum cholesterol and triglyceride levels in animal models and would be beneficial in therapy for hyperlipidemia. Synthesis of 4′-(trifluoromethyl)-2-biphenylcarboxylic acid (xenalipin) has been reported. Xenalipin has been synthesized in the [14C]-labelled form, with specific activity 21.0mCi/mmol, which is suitable for the metabolism and distribution studies in animals.
上流・下流製品情報
上流原料
サプライヤー50 社
関連反応
関連ノート
読み込み中…